Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2018 February;37(1) > International Angiology 2018 February;37(1):46-51

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

INTERNATIONAL ANGIOLOGY

Rivista di Angiologia


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37


eTOC

 

ORIGINAL ARTICLE  


International Angiology 2018 February;37(1):46-51

DOI: 10.23736/S0392-9590.17.03885-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Carbon-coated self-expandable stents in patients with atherosclerotic iliac artery disease

Nicola TROISI , Leonardo ERCOLINI, Emiliano CHISCI, Pierfrancesco FROSINI, Filippo TURINI, Stefano MICHELAGNOLI

Unit of Vascular and Endovascular Surgery, Department of Surgery, San Giovanni di Dio Hospital, Florence, Italy


PDF  


BACKGROUND: The aim of this study was to evaluate the safety and effectiveness of carbon-coated self-expandable stents in the revascularization of atherosclerotic iliac artery lesions.
METHODS: Between January 2012 and June 2016 54 carbon-coated self-expandable stents (Easy HiFlype and Easy Flype; manufactured by CID S.p.A., a member of Alvimedica Group, Istanbul, Turkey) in 40 patients were implanted in our Center. Early and 2-year outcomes have been evaluated in terms of major morbidity, mortality, primary patency, primary assisted patency, secondary patency, absence of target lesion restenosis (TLR), healing of the lesions/relief of symptoms, and limb salvage.
RESULTS: The patients were predominantly males (32/40, 80%) with a mean age of 71 years (range 46-94). One patient (2.5%) had a documented nickel allergy. Mean duration of follow-up was 13.9 months (range 1-48). At 30 days no patient died and 1 patient underwent surgical revision of percutaneous femoral access. The estimated 2-year primary patency, primary assisted patency, secondary patency, absence of TLR, and limb salvage were 92.8%, 93.1%, 95.7%, 79.5%, and 100%, respectively. At univariate analysis none of the pre- or intra-operative factors significantly affected the primary and primary assisted patency rates. Secondary patency was significantly affected by absence of post-stent balloon dilatation (P=0.003). Absence of TLR was significantly affected by age more than 80 years (P=0.01) and common iliac artery lesions (P=0.02). These significances were confirmed at Cox regression analysis.
CONCLUSIONS: Use of carbon-coated self-expandable stents in atherosclerotic iliac lesions was safe and effective. At 2 years, the patency rates and the absence of TLR were encouraging. Post-stent balloon dilatation should be recommended in all cases. Older patients and common iliac artery lesions were risk factors for restenosis in the mid-term period.


KEY WORDS: Self-expandable metallic stents - Iliac artery - Atherosclerotic plaque

inizio pagina

Publication History

Issue published online: January 2, 2018
Article first published online: October 10, 2017
Manuscript accepted: October 6, 2017
Manuscript revised: September 20, 2017
Manuscript received: July 13, 2017

Per citare questo articolo

Troisi N, Ercolini L, Chisci E, Frosini P, Turini F, Michelagnoli S. Carbon-coated self-expandable stents in patients with atherosclerotic iliac artery disease. Int Angiol 2018;37:46-51. DOI: 10.23736/S0392-9590.17.03885-8

Corresponding author e-mail

troisimd@gmail.com